We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12.3B
AUM Growth
+$1.06B
Cap. Flow
+$761M
Cap. Flow %
6.18%
Top 10 Hldgs %
58.32%
Holding
100
New
18
Increased
36
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$896M
2
COL
Rockwell Collins
COL
+$339M
3
MON
Monsanto Co
MON
+$161M
4
ELV icon
Elevance Health
ELV
+$131M
5
CHTR icon
Charter Communications
CHTR
+$92.5M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$508M
2
TWX
Time Warner Inc
TWX
+$393M
3
HDS
HD Supply Holdings, Inc.
HDS
+$196M
4
KITE
Kite Pharma, Inc.
KITE
+$175M
5
ALR
Alere Inc
ALR
+$138M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 13.94%
3 Communication Services 13.94%
4 Financials 11.79%
5 Industrials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFX icon
26
Equifax
EFX
$22B
$153M 1.24%
1,299,175
+9,175
+0.7% +$1.03M
LBTYK icon
27
Liberty Global Class C
LBTYK
$3.5B
$139M 1.13%
4,102,123
+1,012,350
+33% +$31.1M
AZN icon
28
AstraZeneca
AZN
$269B
$131M 1.06%
1,882,500
+292,500
+18% +$19.7M
RDUS
29
DELISTED
Radius Health, Inc.
RDUS
$125M 1.02%
3,936,300
– –
LBTYA icon
30
Liberty Global Class A
LBTYA
$3.59B
$117M 0.95%
3,270,180
+277,245
+9% +$8.81M
VEON icon
31
VEON
VEON
$3.5B
$113M 0.92%
1,177,341
– –
HUN icon
32
Huntsman Corp
HUN
$2.1B
$80.7M 0.66%
2,425,000
-1,075,000
-31% -$32.9M
KYNB
33
Kyntra Bio
KYNB
$27.4M
$78.6M 0.64%
66,300
+22,300
+51% +$28M
BMY icon
34
Bristol-Myers Squibb
BMY
$129B
$73.1M 0.59%
1,192,500
-162,500
-12% -$10.2M
AKRX
35
DELISTED
Akorn Inc
AKRX
$72.6M 0.59%
2,251,300
-28,700
-1% -$941K
ABBV icon
36
AbbVie
ABBV
$465B
$67.7M 0.55%
700,000
+115,000
+20% +$10.8M
SAGE
37
DELISTED
Sage Therapeutics
SAGE
$65.9M 0.54%
400,000
+156,500
+64% +$15.2M
GNCMA
38
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$64.1M 0.52%
1,643,800
– –
ABLX
39
DELISTED
Ablynx NV
ABLX
$58.7M 0.48%
+2,350,000
New +$53.1M
ANAB icon
40
AnaptysBio
ANAB
$1.54B
$56.5M 0.46%
561,000
+315,000
+128% +$23.2M
ENTA icon
41
Enanta Pharmaceuticals
ENTA
$362M
$54.3M 0.44%
925,000
+512,667
+124% +$25.7M
QCOM icon
42
Qualcomm
QCOM
$164B
$50.6M 0.41%
789,783
+704,783
+829% +$42.7M
XLRN
43
DELISTED
Acceleron Pharma
XLRN
$46.2M 0.38%
1,088,000
+125,000
+13% +$4.69M
FOLD
44
DELISTED
Amicus Therapeutics
FOLD
$40M 0.33%
2,781,000
-2,300,055
-45% -$31.6M
MYOK
45
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$36.4M 0.3%
863,732
+466,232
+117% +$18M
ZGNX
46
DELISTED
Zogenix, Inc.
ZGNX
$34M 0.28%
850,000
+530,000
+166% +$20.4M
RC
47
Ready Capital
RC
$260M
$33.3M 0.27%
2,200,007
-124,229
-5% -$1.95M
SVRA icon
48
Savara
SVRA
$1.08B
$33M 0.27%
2,225,000
– –
IONS icon
49
Ionis Pharmaceuticals
IONS
$8.93B
$32.4M 0.26%
645,000
+195,000
+43% +$10.7M
GRFS
50
Grifois
GRFS
$5.55B
$32.3M 0.26%
1,408,760
-21,013
-1% -$467K
1
2
3 4

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Farallon Capital Management held 100 positions worth $12.3B, up 9.4% from $11.3B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Farallon Capital Management deployed $761M of net new capital in Q4 2017, opening 18 new positions and adding to 36 existing holdings. Its largest new stake was Aetna Inc: 5,215,000 shares worth $941M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Time Warner Inc, an estimated $393M trimmed.

  • Farallon Capital Management's largest Q4 2017 buy was Aetna Inc: 5,215,000 shares worth $941M.
  • Farallon Capital Management added most to Monsanto Co in Q4 2017, an estimated $161M increase.
  • Farallon Capital Management's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $393M.
  • Farallon Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $508M.
  • Farallon Capital Management's ten largest holdings make up 58% of its $12.3B portfolio in Q4 2017.
  • Farallon Capital Management opened 18 new positions and closed 19 in Q4 2017.
  • Farallon Capital Management's portfolio value rose 9.4% quarter-over-quarter to $12.3B.

Based on Farallon Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.